Literature DB >> 2162830

Induction of ornithine decarboxylase by nerve growth factor in PC12 cells: dissection by purine analogues.

C Volonté1, L A Greene.   

Abstract

Purine analogues were used to probe the mechanism by which nerve growth factor (NGF) and other agents regulate cellular ornithine decarboxylase (ODC) activity. Exposure of cultured rat pheochromocytoma PC12 cells to NGF causes a 10-50-fold induction of ODC activity within 4-6 h. We recently found that purine analogues block this induction as well as other, but not all, actions of NGF and have provided evidence that the inhibitory actions of the analogues may be due in part to the suppression of an NGF-activated protein kinase activity (Volonté, C., Rukenstein, A., Loeb, D. M., and Greene, L. A. (1989) J. Cell Biol. 109, 2395-2403). The present results show that the purine analogues also suppress the induction of ODC mRNA. One of the analogues used was 6-thioguanine (6-TG). Although 6-TG was effective when applied simultaneously with NGF, if NGF was administered for as little as 1-3 min before 6-TG, ODC induction was unimpaired. This suggests that 6-TG blocks an early step in the NGF mechanism, and that once this step is triggered, the ODC induction pathway is no longer sensitive to this analogue. In contrast, another purine analogue, 2-aminopurine (2-AP), effectively inhibited ODC induction even if applied only during the last hour of a 5-h exposure to NGF. It is hypothesized that this increased period of sensitivity to 2-AP may be due to its broader range (as compared to 6-TG) as an inhibitor of protein kinase activities. Epidermal growth factor (EGF) and cAMP derivatives also induce ODC activity in PC12 cells, and these effects were suppressed by 6-TG and 2-AP at concentrations similar to those that affect responses to NGF. However, short term (less than 30 min) pretreatment with EGF or a cAMP derivative did not protect induction of ODC activity by these agents from inhibition by 6-TG. This suggests that there are both convergent and divergent elements in the mechanistic pathways used by NGF, cAMP analogues, and EGF to induce ODC.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2162830

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Expression profiling upon Nex1/MATH-2-mediated neuritogenesis in PC12 cells and its implication in regeneration.

Authors:  Martine Uittenbogaard; Anne Chiaramello
Journal:  J Neurochem       Date:  2004-12       Impact factor: 5.372

Review 2.  Identification of tyrosine kinase Trk as a nerve growth factor receptor.

Authors:  A H Ross
Journal:  Cell Regul       Date:  1991-09

3.  Nerve growth factor employs multiple pathways to induce primary response genes in PC12 cells.

Authors:  A Batistatou; C Volonté; L A Greene
Journal:  Mol Biol Cell       Date:  1992-03       Impact factor: 4.138

4.  Association of a purine-analogue-sensitive protein kinase activity with p75 nerve growth factor receptors.

Authors:  C Volonté; A H Ross; L A Greene
Journal:  Mol Biol Cell       Date:  1993-01       Impact factor: 4.138

5.  Mediation of NGF-stimulated extracellular matrix invasion by the human melanoma low-affinity p75 neurotrophin receptor: melanoma p75 functions independently of trkA.

Authors:  J L Herrmann; D G Menter; J Hamada; D Marchetti; M Nakajima; G L Nicolson
Journal:  Mol Biol Cell       Date:  1993-11       Impact factor: 4.138

Review 6.  Trophic factors and central nervous system metastasis.

Authors:  G L Nicolson; D G Menter
Journal:  Cancer Metastasis Rev       Date:  1995-12       Impact factor: 9.264

7.  Neuronal growth and survival mediated by eIF5A, a polyamine-modified translation initiation factor.

Authors:  Yunfei Huang; Daniel S Higginson; Lynda Hester; Myung Hee Park; Solomon H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-28       Impact factor: 11.205

Review 8.  The role of trophic factors and autocrine/paracrine growth factors in brain metastasis.

Authors:  D G Menter; J L Herrmann; G L Nicolson
Journal:  Clin Exp Metastasis       Date:  1995-03       Impact factor: 5.150

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.